Haut.AI Launched New AI-Driven Body Analysis as Customer Demand for Personalized Bodycare Accelerates

Haut.AI, the award-winning key players in AI-based skin intelligence and generative skincare personalization, announced the launch of its novel Body Analysis platform, a first-of-its-kind AI-driven body skin analysis technology, intended to support cosmetic and health care brands in delivering targeted, data-driven bodycare experiences for beauty patients at scale. Consumers recently tried the body skin analysis and body care product recommendation platforms.

The launch comes as the worldwide cosmetic market grows 10% year-on-year, with NielsenIQ data representing that over half of today’s customers are looking for AI-driven shopping tools to personalize their consumption. Haut.AI's platform tackles this precise moment, transporting clinically up-to-date AI skin analysis and targeted product recommendations to support brands actively addressing increasing consumer demand for extra intelligent and personalized bodycare advanced services.

The announcement is accompanied by novel customer research revealing wide-body skin challenges and increasing customers' frankness toward AI-based body care leadership. Based on the survey of 1,238 U.S. women, 80% of respondents feel burdened to have healthy-looking and flawless skin, about 40% feel insecure showing their body skin, and 43% have reformed plans as a result of body skin challenges.

Bringing AI Skin Intelligence Beyond the Face

Haut.AI's novel body analysis component is increasing the company's AI-based skin-analysis platform beyond the face. The procedures deliver objective, quantitative skin dimensions in the full body via a single unified pipeline in Haut.AI's suite of AI-driven skin intelligence services.

Haut.AI's generative AI solution is positioned as a first-of-its-kind full-body skin analysis stand for B2B beauty and healthcare partners. The technology's significant differentiator is its unified model, which covers each body region without relying on fragmented or body-part-centric technology.

The technology remained trained on more than 100,000 skin images in the various body parts and validated in all six Fitzpatrick skin types (FST1–FST6) and genders as part of Haut.AI's fairness-by-design strategies to AI-driven skin analysis. Body coverage including face, neck, torso (front and back), arms, hands (palm and dorsal), legs, and feet. All areas are analyzed via a solo segmentation model, and the platform allows product recommendations and targeted bodycare experiences.

"Consumers rarely expect bodycare products to deliver visible results beyond basic moisturization, largely because products are not properly matched to their individual skin needs," said Anastasia Georgievskaya, CEO & Co-Founder of Haut.AI and a scientist with a Master's degree in bioengineering and biophysics. "Body skin is just as complex as facial skin, yet while the beauty industry has developed sophisticated systems for facial skin analysis and recommendations, brands have lacked the infrastructure needed to deliver the same level of intelligence and personalization for body care. Body Analysis changes that by providing objective, quantitative skin data across the full body through a unified AI model, enabling more precise product recommendations, better consumer outcomes, and stronger long-term trust in the category."

According to Towards Healthcare, the Generative AI in Healthcare Market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 3.58 billion in 2026 to approximately USD 53.68 billion by 2035, representing a compound annual growth rate (CAGR) of 35.1% from 2026 to 2035, driven by generative AI-driven technology is significantly transforming research and life sciences by speeding-up drug development, clinical discovery, and health care knowledge synthesis. GenAI has the strength to enhance clinical trial effectiveness by improving recruitment, real-world evidence, and protocol generation analysis. Over time, these competences support transition medical care research toward continuously learning healthcare ecosystems driven by AI-based discovery and large-scale data intelligence. Generative AI allows medical care teams to work more effectively with reports, patient data, imagery, science, and advanced practice.

About Haut.AI

Haut.AI is a SaaS technology industry at the significant of generative AI-driven skincare personalization and skin intelligence. Originated by scientists and AI modernizers, the company has built exclusive technology that turns skin data into objective, computable intelligence across all skin tones and body areas. Haut.AI is partnering with leading worldwide cosmetical and healthcare brands such as Beiersdorf, Neutrogena, Ulta Beauty, and Grupo Boticário, allowing them to deliver science-backed, hyper-targeted skincare experiences that drive measurable customer engagement and commercial impact.

A recent report by Towards Healthcare highlights that the generative AI in healthcare market is witnessing growth because GenAI is redesigning the nature of medical care work. Physicians are progressively shifting from being the main processors of data to validators and orchestrators of AI-based insights. GenAI significantly transforms medical care from reactive, sporadic care delivery toward incessant, predictive, and targeted health management. Generative AI in medical care streamlines day-to-day operations, lessens work burden, enhances patient care, and increases hospital effectiveness. A generative AI tool that also supports general physician while consultations enhances the quality of clinical decision-making without compromising patient safety. The technology led to advanced diagnostic assessments and management plans; demonstrable enhancement in patients’ health results was observed in the short term.